VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 145 filers reported holding VIR BIOTECHNOLOGY INC in Q4 2020. The put-call ratio across all filers is 1.24 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $3,703,254 | -18.6% | 416,096 | -7.3% | 0.00% | 0.0% |
Q1 2024 | $4,547,965 | +55.9% | 448,960 | +54.8% | 0.00% | 0.0% |
Q4 2023 | $2,917,571 | -31.6% | 290,017 | -36.3% | 0.00% | 0.0% |
Q3 2023 | $4,268,512 | -60.5% | 455,551 | +3.4% | 0.00% | -66.7% |
Q2 2023 | $10,810,788 | -6.2% | 440,717 | -11.0% | 0.00% | 0.0% |
Q1 2023 | $11,525,818 | -8.2% | 495,308 | -0.2% | 0.00% | -25.0% |
Q4 2022 | $12,559,479 | +28.7% | 496,226 | -1.9% | 0.00% | +33.3% |
Q3 2022 | $9,755,000 | -21.1% | 505,946 | +4.2% | 0.00% | -25.0% |
Q2 2022 | $12,370,000 | +1096.3% | 485,660 | +1108.5% | 0.00% | – |
Q1 2022 | $1,034,000 | -86.5% | 40,188 | -78.1% | 0.00% | -100.0% |
Q4 2021 | $7,671,000 | +403.3% | 183,201 | +423.3% | 0.00% | – |
Q3 2021 | $1,524,000 | +3.0% | 35,008 | +11.9% | 0.00% | – |
Q2 2021 | $1,479,000 | +65.8% | 31,290 | +79.8% | 0.00% | – |
Q1 2021 | $892,000 | +191.5% | 17,398 | +52.1% | 0.00% | – |
Q4 2020 | $306,000 | -68.6% | 11,438 | -51.9% | 0.00% | – |
Q2 2020 | $975,000 | – | 23,804 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bill & Melinda Gates Foundation | 1,559,142 | $39,700,000 | 30.52% |
SB INVESTMENT ADVISERS (UK) LTD | 22,216,644 | $565,858,000 | 4.50% |
Zebra Capital Management LLC | 25,419 | $647,000 | 1.90% |
Alaska Permanent Fund Corp | 2,300,000 | $58,581,000 | 0.84% |
CLARK ESTATES INC/NY | 180,000 | $4,585,000 | 0.79% |
Temasek Holdings (Private) Ltd | 5,602,553 | $142,697,025 | 0.78% |
SECTOR GAMMA AS | 110,223 | $2,807,000 | 0.63% |
Avidity Partners Management LP | 758,211 | $19,312,000 | 0.44% |
New Vernon Capital Holdings II LLC | 14,501 | $369,000 | 0.30% |
DUALITY ADVISERS, LP | 116,415 | $2,965,000 | 0.29% |